C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection
BMC Infectious Diseases volume 10, Article number: 288 (2010)
Data for predicting which patients with pandemic influenza A (H1N1) infection are likely to run a complicated course are sparse. We retrospectively studied whether the admission serum C-reactive protein (CRP) levels can serve as a predictor of illness severity.
Included were all consecutive adult patients who presented to the emergency department (ED) between May-December, 2009 with a flu-like illness, a confirmed diagnosis of pandemic influenza A (H1N1) infection and a serum CRP level measured within 24 hours of presentation. Patients with a proven additional concurrent acute illness (e.g., bacteremia) were excluded. We used the ROC curve analysis, Kaplan-Meier curves and the Cox proportional hazard model to evaluate the predictive ability of CRP as a prognostic factor.
Seventeen (9%) of the 191 enrolled patients were admitted to the intensive care unit (ICU), of whom eight (4%) required mechanical ventilation and three (2%) died. The median admission serum CRP levels were significantly higher among patients who required subsequent ICU care and mechanical ventilation than among patients who did not (123 mg/L and 112 mg/L vs. 40 mg/L, p < .001 and 43 mg/L, p = .017, respectively). A Cox proportional hazard model identified admission serum CRP levels and auscultatory findings over the lungs as independent prognostic factors for ICU admission. Admission serum CRP levels were the only independent prognostic factor for mechanical ventilation. Thirty days after presenting to the ED, none of the patients with admission serum CRP level <28 mg/L (lower tertile) required either ICU admission or mechanical ventilation. At the same time point, 19% of the patients with admission serum CRP level ≥70 mg/L (upper tertile) needed to be admitted to the ICU and 8% of the same upper tertile group required mechanical ventilation. The differences in the rates between the lower vs. upper tertile groups were significant (Log-Rank p < .001 for ICU and p < .024 for mechanical ventilation).
In our study group, serum CRP levels obtained in the early ED admission stage from patients presenting with pandemic H1N1 influenza A infection were found to serve as a useful gauge for predicting disease course and assisting in patient management.
The clinical manifestations of pandemic H1N1 influenza A infection range from a relatively mild and self-limiting respiratory infection to a severe illness with significant morbidity and mortality [1, 2]. There is no single laboratory test that can serve as a potential biomarker to identify the patients at high risk for a complicated clinical course. Shortly after the pandemic reached our catchment area, we noted that some of the patients who needed to be hospitalized for severe H1N1 infection had high serum levels of C-reactive protein (CRP), which are usually seen in systemic bacterial infections and not in viral respiratory diseases [3–6]. High serum CRP levels were found in patients affected by Corona virus during the severe acute respiratory syndrome (SARS) outbreak in 2002 [7, 8], when they were also identified as predictors of respiratory failure and death [7–9].
The current retrospective study examined serum CRP levels obtained during the first 24 hours since admission to emergency department (ED) as a predictor of illness severity among patients infected with the 2009 pandemic influenza A (H1N1). The evaluation compared the predictive capacity of serum CRP levels with that of other factors, such as underlying medical conditions, vital signs, physical signs, chest radiograph findings and laboratory test results.
The study was approved by the local ethics committee of the Tel Aviv Sourasky Medical Center, and informed patient consent was waived due to the observational nature of the study. The setting for this investigation was a single tertiary care university-affiliated medical center. The Tel Aviv Sourasky Medical Center serves a population of 1 million citizens in the Tel Aviv municipal area. All of the patients were 18 years of age or older. Data were collected for all consecutive patients admitted to the ED between May 1 and December 31, 2009, who fulfilled the clinical criteria for confirmed H1N1 influenza infection as established by the United States Centers for Disease Control and Prevention (CDC). These criteria included flu-like symptoms, such as a body temperature of 37.8°C (100°F) or higher, cough or sore throat, and a real-time reverse transcriptase polymerase chain reaction assay (RT-PCR) positive for H1N1 virus . All patients whose serum CRP levels were measured within 24 hours of presentation to the ED were eligible for inclusion, whether they were subsequently hospitalized or discharged after initial evaluation. Following a review of patients' charts and records for symptoms and signs, laboratory and imaging findings, and blood and urine cultures (when available), patients with a proven additional concurrent acute illness (e.g., bacteremia) were excluded from the study.
Patients' records were reviewed for demographics, background diseases (including obesity, diabetes, current smoking, asthma, chronic obstructive pulmonary disease (COPD), ischemic heart disease (IHD), congestive heart failure (CHF), and active cancer), pregnancy, permanent steroid therapy, current chemotherapy, physical signs, vital signs, laboratory findings, chest radiograph findings, length of hospitalization, admission to the intensive care unit (ICU), need for mechanical ventilation, and death. The following times were also noted: from the first symptom to admission, from admission to ICU, provision of mechanical ventilation, and death. Radiologists unaware of patients' clinical data and outcome reviewed all chest radiographs obtained within 24 hours of admission to the ED, for findings characteristic of H1N1 pneumonia in adults, according to recently published descriptions [11, 12]. The main outcome measures were whether or not the patient was admitted to the ICU, if mechanical ventilation was required and death. Follow-up of all the enrolled patients was managed via a telephone survey conducted at least 30 days since hospital admission. The query items focused on the appearance of any additional symptoms, the administration of any additional medical treatment, re-hospitalization, and outcome.
Values are presented as means ± SD or median and interquartile range (IQR) for the continuous variables and as number of individuals (and the percentage in each group) for the categorical variables. The comparison of continuous variables between groups was by independent samples Student's t-test for normally distributed variables and by the Mann-Whitney U statistics for non-normally distributed variables. Frequencies of categorical variables were compared by the Fisher exact test. In order to assess CRP as an early predictor of outcome, a receiver operating characteristic (ROC) curve was plotted and the area under the curve was calculated to determine the predictive ability of different CRP serum level cutoff values for the different outcomes . Primary outcomes of required transfer to ICU and mechanical ventilation were evaluated on a time-to-event basis by Kaplan-Meier analysis with the use of the log-rank statistics to test for determining differences in the rates of the end points according to serum CRP levels. Cox proportional-hazard modeling was used, applying the forward stepwise analysis method to assess the effects of potential outcome markers. The SPSS statistical package was used to perform all the statistical evaluations (SSPS Inc., Chicago, IL, USA). For all analyses, a value of p < .05 (two-tailed) was considered to indicate statistical significance.
During the study period, 315 adult patients who fulfilled the CDC clinical criteria for confirmed H1N1 influenza virus infection  were admitted to the ED. In 209 of these patients (66%), serum CRP levels were measured within 24 hours of admission. Blood and urine cultures were obtained on admission in 110 (53%) and in 65 (31%) of these 209 patients, respectively. Eighteen patients (9%) were excluded from this study due to a concurrent acute illness on presentation. Consequently, the final study cohort comprised 191 patients whose serum CRP levels were obtained within 24 hours of admission and whose sole acute illness was a confirmed diagnosis of H1N1 influenza-virus infection. Patients' mean age was 43 ± 16 years (range 18-85). There were 95 (50%) female and 96 (50%) male patients. The most common background medical conditions were active smoking (n = 50, 26%), asthma (n = 37, 19%), diabetes mellitus (n = 24, 13%) and COPD (n = 22, 12%).
The median time from symptom onset until presentation to the ED was 72 hours (IQR 48-120). The median time from admission until first serum CRP level determination was 1 hour and 17 minutes. One hundred sixty eight (88%) patients were hospitalized and 23 (12%) were discharged to their homes after the initial evaluation in the ED. The median length of hospitalization was 3 days [2–5].
Seventeen (9%) patients were admitted to the ICU, of whom eight (4%) required mechanical ventilation and three died (2%). All 185 (98%) of the 188 surviving patients contacted through a follow-up telephone survey described an unremarkable clinical course of the disease in the thirty days since they presented at the ED.
With the exception of one patient who was transferred directly from the ED to the ICU, all of the admitted patients were first transferred from the ED to a hospital ward. Sixteen patients were subsequently transferred to the ICU. The median time from admission to the ED to transfer to the ICU was 53 hours (IQR 23-65). There was no significant difference in the prevalence of background medical conditions among the patients who required hospitalization in the ICU and those who did not (data not shown). The median time between the onset of first symptoms until presentation to the ED was similar for both hospitalized groups (Table 1).
Low blood oxygen saturation (≤90%) on presentation to the ED and abnormal auscultatory findings over the lung fields (bronchial breath sounds or crackles) on admission were more common in the patients who were eventually admitted to ICU compared to those who remained in the wards (Table 1). The same clinical observation was noted in regard to patients who required mechanical ventilation compared to those who did not; however, in this comparison, the difference was not statistically significant (data not shown). Seventy-four of the 177 (93%) patients who underwent chest radiography within 24 hours of admission had findings consistent with pneumonia. The prevalence of these findings was significantly higher among the patients who required ICU care compared with those who did not (Table 1). Chest radiographic findings consistent with pneumonia were also more prevalent among patients who required mechanical ventilation than among those who did not, but this difference was not significant (6/8 (75%) vs. 68/170 (40%), respectively, p = .069).
Among the evaluated laboratory parameters, serum CRP levels and neutrophil percentage in a complete blood count (CBC) obtained within 24 hours of admission comprised the only two factors that significantly differentiated between patients who needed to be admitted to the ICU and those who could remain on the ward (Table 1). Unfortunately, we could not include the parameter of patients' blood gases in the current analysis, since such a sample was obtained from only a few of the patients.
Serum CRP levels were the only laboratory parameter that significantly differentiated between patients who required mechanical ventilation and those who did not (112 mg/L [IQR 45-180] vs. 43 mg/L [IQR 22-89], respectively, p = .017). Figures 1 and 2 display box-plots of serum CRP levels, according to ICU admission and need for mechanical ventilation, respectively.
The ability to consider serum CRP levels obtained during the first 24 hours of ED admission as a biomarker for predicting pandemic H1N1 influenza A patients' need for ICU care or mechanical ventilation was evaluated using ROC curve analysis. The small number of deaths in our cohort precluded the performing of ROC curve analysis for that outcome. The area under the curve (AUC) for ICU admission was 0.82 (95% CI = 0.73-0.91; p < .001). The AUC for mechanical ventilation was 0.75 (95% CI = 0.60-0.90; p = .017). The sensitivity, specificity and positive and negative predictive values (PPV and NPV) for ICU admission and mechanical ventilation of serum CRP at different cut-off levels are displayed in Table 2.
The Cox proportional hazard model was applied to assess the ability of the following factors to predict the need for ICU admission: low oxygen saturation (≤90%), abnormal auscultatory findings over lung fields, chest radiograph findings consistent with pneumonia, percentage of neutrophil in a CBC, and serum CRP levels. The first variable that entered the model was CRP (p = .001), followed by abnormal auscultatory findings (p = .028). None of the other three variables entered the model afterwards. The CRP hazard ratio (95% confidence interval [CI]) for transfer to the ICU was 1.09 (1.06-1.12) for each increase of 10 mg/L in CRP level. The hazard ratio (95% CI) of presence of auscultatory findings over the lung fields for being transferred to the ICU was 3.85 (1.16-12.8).
The Cox proportional hazard model was applied to assess the ability of serum CRP level to predict the need for mechanical ventilation. The CRP level was the only variable that entered the model (p = .018), and the hazard ratio (95% CI) for mechanical ventilation was 1.09 (1.05 - 1.13) for each increase of 10 mg/L in CRP level.
A Kaplan-Meier estimate of the two main outcome measures, i.e., the need for ICU admission and for mechanical ventilation, was performed using tertiles of serum CRP levels (i.e., <28, 28-69, and ≥70 mg/L). At the 30-day time point since their presentation to the ED, none of the patients with a serum CRP level <28 mg/L (lower tertile) needed to be admitted to the ICU or required mechanical ventilation (Figures 3 and 4). At the same time point, 19% of the patients with a serum CRP level ≥70 mg/L (upper tertile) needed to be admitted to the ICU and 8% required mechanical ventilation. The differences in the rates between the lower vs. upper tertile groups were significant (Log-Rank p < .001 for ICU and p < .024 for mechanical ventilation).
The results of the study confirm that low saturation (< 90%), auscultatory findings over the lung fields, findings consistent with pneumonia on chest radiography, high percentage of neutrophil in a CBC and high serum CRP levels at the time of presentation to the ED are associated with a severe course of H1N1 influenza A virus infection. Of these variables, serum CRP levels were found to be the best predictor of subsequent need for ICU admission and the only predictor of subsequent need for mechanical ventilation.
Moreover, low initial serum CRP levels were an excellent predictor of good outcome: at 30 days from admission, none of the patients with CRP levels lower than 33 mg/L required either ICU care or mechanical ventilation. The fact that patients with low serum CRP levels enjoyed good outcome may serve as a guiding tool, enabling the assessing clinician in the ED to differentiate between "low risk" patients vs. "high risk" patients. As evident from Table 2, a cut-off value of 33 mg/L is a viable choice that achieves 100% sensitivity but a specificity of only around 40% for ICU admission or mechanical ventilation. By comparison, a slightly higher CRP cut-off of 64 mg/L achieved lower but acceptable sensitivities of 82% and 75% for ICU admission and mechanical ventilation, respectively, with higher specificities of 68% and 65%, respectively. Thus, it appears that serum CRP levels may have a significant role in helping the physician in the decision making process on the individual patient level.
The high serum CRP levels that were observed among some of the patients in our series are usually found among patients with bacterial infections [3–6]. Two series of studies of lung specimens taken from autopsies of patients who died in the recent pandemic reported that many of the victims had a proven secondary bacterial infection. Gill et al.  found histologic and microbiologic evidence of bacterial pneumonia in 55% of 34 people who died following a confirmed pandemic influenza A H1N1 virus infection. Similar findings were found in 29% of lung specimens from 77 fatal cases in another series . Thus, it is plausible that the high CRP levels among some of the patients in the current study may represent a secondary bacterial infection. Another possible explanation is that the high serum CRP levels represent a severe inflammatory response to the H1N1 virus. A similar hypothesis was suggested with regards to SARS, which was caused by the Corona virus in the 2002 outbreak. It was postulated that exaggerated activation of cytokines/chemokines played an significant role in the pathogenesis of the disease leading to an adverse outcome [16, 17]. Either one of the aforementioned explanations is compatible with the current findings, which indicate that CRP levels may serve as a useful biomarker for predicting disease severity among patients with suspected or confirmed H1N1 influenza A virus infection.
One of the major limitations of the current work is its retrospective nature and the relatively small number of patients with a severe outcome. The absence of an agreed protocol for the measurement of serum CRP in patients with H1N1 virus infection admitted to the ED led to the exclusion of 34% of the 315 patients from the study cohort and may have also biased the results. Thus, it may make it difficult to extrapolate the results to another population. Despite these limitations, the association between CRP levels upon presentation to the ED and patient outcome was significant and substantial. Another potential limitation is the need for ICU care as a measurement of outcome severity, since the decision itself might have been based on, among other factors, admission serum CRP levels. Only one patient in this series was admitted to the ICU directly from the ED.
In the current sample of patients with pandemic H1N1 influenza A infection, the serum CRP levels obtained during the first 24 hours since presentation to the ED were found to be significantly correlated with impending disease severity. Based on this finding, it is plausible that this measurement may serve as a useful early biomarker to identify patients at high risk for a complicated clinical course of the disease. The ability to differentiate between high and low risk patients has clear-cut clinical and therapeutic implications for decision-making on issues of patient management.
Intensive care unit
Severe acute respiratory syndrome
Centers for Disease Control and Prevention
Real-time reverse transcriptase polymerase chain reaction assay
Chronic obstructive pulmonary disease
Ischemic heart disease
Congestive heart failure
Receiver operating characteristic
Complete blood count
Area under the curve
Positive predictive values
Negative predictive values
White blood cells
World Health Organization: Pandemic (H1N1) 2009 - update 76. [http://www.who.int/csr/don/2009_11_27a/en/index.html]
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009, 360: 2605-2615. 10.1056/NEJMoa0903810.
Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999, 340: 448-454. 10.1056/NEJM199902113400607.
Melbye H, Hvidsten D, Holm A, Nordbø SA, Brox J: The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract. 2004, 54: 653-658.
Smith RP, Lipworth BJ: C-reactive protein in simple community-acquired pneumonia. Chest. 1995, 107: 1028-1031. 10.1378/chest.107.4.1028.
Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH: C-reactive protein. A clinical marker in community-acquired pneumonia. Chest. 1995, 108: 1288-1291. 10.1378/chest.108.5.1288.
Wang JT, Sheng WH, Fang CT, Chen YC, Wang JL, Yu CJ, Chang SC, Yang PC: Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004, 10: 818-824.
Jang TN, Yeh DY, Shen SH, Huang CH, Jiang JS, Kao SJ: Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases. J Infect. 2004, 48: 23-31. 10.1016/j.jinf.2003.09.004.
Chang HL, Chen KT, Lai SK, Kuo HW, Su IJ, Lin RS, Sung FC: Hematological and biochemical factors predicting SARS fatality in Taiwan. J Formos Med Assoc. 2006, 105: 439-50. 10.1016/S0929-6646(09)60183-2.
U.S. Centers for Disease Control and Prevention Website: Interim guidance on specimen collection, processing, and testing for patients with suspected novel influenza A (H1N1) virus infection. [http://www.cdc.gov/h1n1flu/specimencollection.htm]
Agarwal PP, Cinti S, Kazerooni EA: Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. Am J Roentgenol. 2009, 193: 1488-1493. 10.2214/AJR.09.3599.
Ajlan AM, Quiney B, Nicolaou S, Müller NL: Swine-origin influenza A (H1N1) viral infection: radiographic and CT findings. Am J Roentgenol. 2009, 1494-1499. 10.2214/AJR.09.3625. 193
Bamber D: The area above the ordinal dominance graph and the area below the receiver operating graph. Journal of Mathematical Psychology. 1975, 12: 387-415. 10.1016/0022-2496(75)90001-2.
Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, Suh J, Deshpande C, Mollura DJ, Morens DM, Bray M, Travis WD, Taubenberger JK: Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010, 134: 235-243.
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009, 58: 1071-1074.
Chien JY, Hsueh PR, Cheng WC, Yu CJ, Yang PC: Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology. 2006, 11: 715-722. 10.1111/j.1440-1843.2006.00942.x.
Sheng WH, Chiang BL, Chang SC, Ho HN, Wang JT, Chen YC, Hsiao CH, Hseuh PR, Chie WC, Yang PC: Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome. J Formos Med Assoc. 2005, 104: 715-723.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/10/288/prepub
This article is dedicated to the memory of Dr. Roy Arad, who passed on unexpectedly before the publication of our study.
Ronen Ben-Ami, M.D., and Talia Finn, M.D. are thanked for reviewing of the manuscript.
The authors declare that they have no competing interests.
OZ participated in the conception, design and coordination of the study, acquisition of data, interpretation of data and manuscript drafting; OR performed the statistical analysis and participated in the design of the study, interpretation of data and manuscript drafting; GA carried out the interpretation of chest radiographs and revised the manuscript for important intellectual content; MM participated in the coordination of the study, acquisition of data and revised the manuscript for important intellectual content; DZ participated in the conception and design of the study and revised the manuscript for important intellectual content; DJ participated in the interpretation of data and took part in the manuscript drafting; ED participated in the interpretation of the data and revised the manuscript for important intellectual content; RA took part in the study design and acquisition of data and revised the manuscript for important intellectual content; OT took part in the study design and acquisition of data and revised the manuscript for important intellectual content; LT took part in the study design and acquisition of data and revised the manuscript for important intellectual content; JT took part in the acquisition of data and revised the manuscript for important intellectual content; SB participated in the study design, interpretation of data and manuscript drafting; YP participated in the conception, design and coordination of the study, acquisition of data, interpretation of data and manuscript drafting. All authors read and approved the final manuscript.
Ofer Zimmerman, Ori Rogowski contributed equally to this work.
About this article
Cite this article
Zimmerman, O., Rogowski, O., Aviram, G. et al. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis 10, 288 (2010). https://doi.org/10.1186/1471-2334-10-288